Hostname: page-component-8448b6f56d-c4f8m Total loading time: 0 Render date: 2024-04-19T14:28:51.879Z Has data issue: false hasContentIssue false
  • English
  • Français

Applying Civil Rights Law to Clinical Research: Title VI’s Equal Access Mandate

Published online by Cambridge University Press:  04 March 2022

Joseph Liss ,
David Peloquin ,
Mark Barnes  and
Barbara E. Bierer
Get access Rights & Permissions [Opens in a new window]

Abstract

Title VI of the Civil Rights Act of 1964 and its implementing regulations prohibit federally-funded educational institutions and healthcare centers from engaging in disparate impact discrimination “on the ground of race, color, or national origin” in all of their operations.

Keywords

DiscriminationEqual ProtectionClinical TrialsTitle VIand Enforcement
Type
Symposium Articles
Information
Journal of Law, Medicine & Ethics , Volume 50 , Issue 1: Health Law and Anti-Racism: Reckoning and Response , Spring 2022 , pp. 101 - 108
Copyright
© 2022 The Author(s)

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Thomas, S.B. and Quinn, S. Crouse, “The Tuskegee Syphilis Study, 1932 to 1972: Implications for HIV Education and AIDS Risk Education Programs in the Black Community,” American Journal of Public Health 81, no. 11 (1991): 1498–1505, available at <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1405662/> (last visited December 6, 2021).CrossRefGoogle ScholarPubMed
Flores, L.E. et al., “Assessment of the Inclusion of Racial/Ethnic Minority, Female, and Older Individuals in Vaccine Clinical Trials,” JAMA Network Open 4, no. 2 (2021): 1–11.CrossRefGoogle ScholarPubMed
“Drug Trials Snapshots,” Food and Drug Administration, 2020, available at <https://www.fda.gov/media/145718/download> (last visited December 6, 2021).+(last+visited+December+6,+2021).>Google Scholar
21st Century Cures Act, Sec. 2053, 42 U.S.C. § 289a–2(c)(2); Food and Drug Administration, Collection of Race and Ethnicity Data in Clinical Trials, FDA-2016-D-3561 (2016), available at <https://www.fda.gov/regulatory-information/search-fda-guidance-documents/collection-race-and-ethnicity-data-clinical-trials> (last visited December 6, 2021).+(last+visited+December+6,+2021).>Google Scholar
US HHS, National Institutes of Health, “Rapid Acceleration of Diagnostics (RADx),” RADx Programs, available at <https://www.nih.gov/research-training/medical-research-initiatives/radx/radx-programs#radx-up> (last visited December 6, 2021).+(last+visited+December+6,+2021).>Google Scholar
Food and Drug Administration, “Enhance EQUITY Initiative,” available at <https://www.fda.gov/consumers/minority-health-and-health-equity/enhance-equity-initiative> (last visited.+(last+visited.>Google Scholar
42 U.S.C. § 2000d (2018); Alexander v. Sandoval, 532 U.S. 275, 280 (2001).Google Scholar
Price Waterhouse v. Hopkins, 490 U.S. 228, 271 (1989) (O’Connor, J., concurring).Google Scholar
42 U.S.C. § 2000d-1 (2018).Google Scholar
45 C.F.R. § 80.3(b)(2) (2019).Google Scholar
U.S. Department of Justice and Department of Health & Human Services Office of Civil Rights, Title VI Child Welfare Guidance, (Washington, DC: December 2019), available at <https://www.justice.gov/crt/title-vi-child-welfare-guidance> (last visited December 6, 2021).+(last+visited+December+6,+2021).>Google Scholar
Lau v. Nichols, 414 U.S. 563 (1974).Google Scholar
Alexander v. Sandoval, 532 U.S. 275, 293 (2001).Google Scholar
Kimmel, A., Epstein, R., and Ferraro, J., “The Sandoval Decision and Its Implications for Future Civil Rights Enforcement,” Florida Bar Journal 76, no. 1 (2002): 24, available at <https://www.floridabar.org/the-florida-bar-journal/the-sandoval-decision-and-its-implications-for-future-civil-rights-enforcement/> (last visited December 6, 2021).Google Scholar
42 U.S.C. § 2000d (2018).Google Scholar
Grove City College v. Bell, 465 U.S. 555, 572 (1984).Google Scholar
Civil Rights Restoration Act of 1987 , Sec. 2, Pub. L. No. 100-259, 102 Stat. 28, 28 (1988).Google Scholar
42 U.S.C. § 2000d–4a (2018).Google Scholar
45 C.F.R. § 80.13(g) (2019).Google Scholar
42 U.S.C. § 2000d–1.Google Scholar
Department of Health and Human Services Office of Civil Rights, “What Qualifies as ‘Federal Financial Assistance’ for Purposes of Civil Rights Complaints Handled by OCR?”, 2015, available at <https://www.hhs.gov/civil-rights/for-individuals/faqs/what-qualifies-as-federal-financial-assistance/301/index.html> (last visited December 6, 2021); Office of Extramural Research, NIH Grants Policy Statement, “Definition of Terms,” at Sec. 1.2, National Institutes of Health, 2021, available at <https://grants.nih.gov/grants/policy/nihgps/html5/section_1/1.2_definition_of_terms.htm> (last visited December 6, 2021).+(last+visited+December+6,+2021);+Office+of+Extramural+Research,+NIH+Grants+Policy+Statement,+“Definition+of+Terms,”+at+Sec.+1.2,+National+Institutes+of+Health,+2021,+available+at++(last+visited+December+6,+2021).>Google Scholar
Amending the Regulations Governing Nondiscrimination on the Basis of Race, Color, National Origin, Handicap, Sex, and Age To Conform to the Civil Rights Restoration Act of 1987, 70 Fed. Reg. 24,314, 24,315.Google Scholar
70 Fed. Reg. at 24,316.Google Scholar
45 CFR § 92.2(a)(1) (2019); Nondiscrimination in Health and Health Education Programs or Activities, Delegation of Authority, 85 Fed. Reg. 37160, 37171 (June 19, 2020).Google Scholar
45 C.F.R. § 80.4(a)(1) (2019).Google Scholar
Office of Extramural Research, NIH Grants Policy Statement, Secs. 4.1.2, 4.1.2.1, 4.1.2.5.Google Scholar
Department of Health and Human Services, Assurance of Compliance, Form 690, 2019, available at <https://www.hhs.gov/sites/default/files/form-hhs690.pdf> (last visited December 6, 2021).+(last+visited+December+6,+2021).>Google Scholar
Office of Extramural Research, “Civil Rights Protections,” NIH Grants Policy Statement, at Secs. 4.1.2, 4.1.2.1, 4.1.2.5.Google Scholar
Department of Health and Human Services, Assurance of Compliance.Google Scholar
McDonnell Douglas Corp. v. Green, 411 U.S. 792, 802 (1973).Google Scholar
Civil Rights Act of 1964, 42 U.S.C. § 2000d; 45 CFR § 80.3.Google Scholar
United States v. McDonnell, 136 S. Ct. 2355, 2369 (2016) (quoting Arlington Central School Dist. Bd. of Ed. v. Murphy, 548 U.S. 291, 299, n. 1 (2006)); Bailey v. United States, 516 U.S. 137, 146 (1995).Google Scholar
Leib, E.J. and Brudney, J.J., “The Belt-and-Suspenders Canon,” Iowa Law Review 105, no. 2 (2020): 737.Google Scholar
Resolution agreement between the U.S. Department of Health and Human Services Office for Civil Rights and the University of Pittsburgh Medical Center, transaction number: 10-106043, Office for Civil Rights, August 2010, available at <https://www.hhs.gov/sites/default/files/ocr/civilrights/activities/agreements/upmcra.pdf> (last visited December 6, 2021).+(last+visited+December+6,+2021).>Google Scholar
Civil Rights Division, “Proving Discrimination — Disparate Impact,” in Title VI Legal Manual.Google Scholar
Civil Rights Division, “Proving Discrimination — Disparate Impact,” in Title VI Legal Manual, Department of Justice, 2021, available at <https://www.justice.gov/crt/fcs/T6Manual7> (last visited December 6, 2021).+(last+visited+December+6,+2021).>Google Scholar
Darensburg v. Metro. Transp. Comm’n, 636 F.3d 511, 519 (9th Cir. 2011) (turning to Title VII disparate impact analysis to analyze a claim similar to Title VI arising under California law); New York Urban League v. New York, 71 F.3d 1031, 1036 (2d Cir. 1995) (applying the burden-shifting framework pre-Sandoval Title VI case); Georgia State Conference of Branches of NAACP v. Georgia, 775 F.2d 1403, 1417 (11th Cir. 1985) (same).Google Scholar
Civil Rights Division, “Proving Discrimination — Disparate Impact,” in Title VI Legal Manual.Google Scholar
Civil Rights Division, “Proving Discrimination — Disparate Impact,” in Title VI Legal Manual; Coalition of Concerned Citizens Against I-670 v. Damian, 608 F. Supp. 110, 127 (S.D. Ohio 1984).Google Scholar
National Institutes of Health, Civil Rights Protections in NIH-Supported Research, Programs, Conferences and Other Activities, NOT-OD-15-152, September 2015, available at <https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-152.html> (last visited December 6, 2021).+(last+visited+December+6,+2021).>Google Scholar
National Institutes of Health, “Civil Rights Protections in NIH-Supported Research, Programs, Conferences and Other Activities.Google Scholar
Muthukumar, A.V., Morrell, W., and Bierer, B. E., “Evaluating the Frequency of English Language Requirements in Clinical Trial Eligibility Criteria: A Systematic Analysis Using ClinicalTrials.gov,” PLoS Medicine 18, no. 9 (2021): e1003758, available at <https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003758> (last visited December 6, 2021).CrossRefGoogle ScholarPubMed
“Recent Civil Rights Resolution Agreements & Compliance Reviews,” Office of Civil Rights, Department of Health and Human Services, available at <https://www.hhs.gov/civil-rights/for-providers/compliance-enforcement/agreements/index.html> (last visited December 6, 2021).+(last+visited+December+6,+2021).>Google Scholar
“Enforcement Success Stories Involving Persons with Limited English Proficiency,” Office of Civil Rights, Department of Health and Human Services, available at <https://www.hhs.gov/civil-rights/for-providers/compliance-enforcement/examples/limited-english-proficiency/index.html> (last visited December 6, 2021).+(last+visited+December+6,+2021).>Google Scholar
“Section 1557: Frequently Asked Questions,” Office of Civil Rights, Department of Health and Human Services, available at <https://www.hhs.gov/civil-rights/for-individuals/section-1557/1557faqs/index.html> (last visited December 6, 2021).+(last+visited+December+6,+2021).>Google Scholar
Byrne, A. and Tanesini, A., “Instilling New Habits: Addressing Implicit Bias in Healthcare Professionals,” Advances in Health Sciences Education 20 (2015): 1255–1262; C. FitzGerald and S. Hurst, “Implicit Bias in Healthcare Professionals: A Systematic Review,” BMC Medical Ethics 18, no. 19 (2017); L. Skopec, D. Gonzalez, and G. M. Kenney, “Most Adults Who Feel Treated or Judged Unfairly by Health Care Providers Report Adverse Consequences,” Urban Institute, August 2021, available at <https://www.urban.org/research/publication/most-adults-who-feel-treated-or-judged-unfairly-health-care-providers-report-adverse-consequences> (last visited December 6, 2021).+(last+visited+December+6,+2021).>Google Scholar
Office of Extramural Research, “Civil Rights Protections” in NIH Grants Policy Statement, at Sec. 4.1.2; Office of Extramural Research, NIH Grants Policy Statement, at Secs 1.2, 4.1.1, 4.1.3.Google Scholar
Food and Drug Administration, Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry, November 2020, available at <https://www.fda.gov/media/127712/download> (last visited December 6, 2021).+(last+visited+December+6,+2021).>Google Scholar
Merz, L.E. and Achebe, M., “When Non-Whiteness Becomes a Condition,” Blood 137, no. (2021): 13–15.Google ScholarPubMed
Bierer, B., White, S., Meloney, L., Ahmed, H., Strauss, D., and Clark, L., Achieving Diversity, Inclusion, and Equity in Clinical Research, Multi-Regional Clinical Trials Center, 2021, available at <https://mrctcenter.org/diversity-in-clinical-research/guidance/guidance-document/> (last visited December 6, 2021).+(last+visited+December+6,+2021).>Google Scholar
Civil Rights Division, “Proving Discrimination — Disparate Impact,” in Title VI Legal Manual, Department of Justice, 2021, available at <https://www.justice.gov/crt/fcs/T6Manual7#Z> (last visited December 6, 2021).+(last+visited+December+6,+2021).>Google Scholar
45 C.F.R. § 80.6(b); accord 28 C.F.R. § 42.406(a); National Institutes of Health, NIH Policy on Reporting Race and Ethnicity Data: Subjects in Clinical Research, NOT-OD-01-053, 2001, available at <https://grants.nih.gov/grants/guide/notice-files/NOT-OD-01-053.html> (last visited December 6, 2021).+(last+visited+December+6,+2021).>Google Scholar
Madison-Hughes v. Shalala, 80 F.3d 1121, 1125 (6th Cir. 1996).Google Scholar
Civil Rights Division, “Proving Discrimination — Disparate Impact,” in Title VI Legal Manual, Department of Justice, 2021, available at <https://www.justice.gov/crt/fcs/T6Manual7#Z> (last visited December 6, 2021); Gillis v. U.S. Dept. of H. H. Services, 759 F.2d 565, 576 (6th Cir. 1985) (finding that monitoring efforts of assurances that recipients provide under the Hill-Burton statute “fall squarely within the agency’s exercise of discretion”).+(last+visited+December+6,+2021);+Gillis+v.+U.S.+Dept.+of+H.+H.+Services,+759+F.2d+565,+576+(6th+Cir.+1985)+(finding+that+monitoring+efforts+of+assurances+that+recipients+provide+under+the+Hill-Burton+statute+“fall+squarely+within+the+agency’s+exercise+of+discretion”).>Google Scholar
Food and Drug Administration, Collection of Race and Ethnicity Data in Clinical Trials, FDA-2016-D-3561, 2016, available at <https://www.fda.gov/regulatory-information/search-fda-guidance-documents/collection-race-and-ethnicity-data-clinical-trials> (last visited December 6, 2021).+(last+visited+December+6,+2021).>Google Scholar
Bierer et al., supra note 50.Google Scholar